Weight management

• 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market - Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
• People who stop taking GLP-1 drugs regain weight faster, review finds - When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those who stopped a diet or exercise program, a new review of studies finds.
• FDA Approves Oral Version of Wegovy, First GLP-1 Pill Approved Specifically for Weight Management - The pill is expected to be available starting in January 2026.